Clinical Trials Directory

Trials / Unknown

UnknownNCT02499016

Suprapubic Single-incision Laparoscopic Appendectomy Versus Conventional Appendectomy: a Randomized Controlled Trial

Suprapubic Single-incision Laparoscopic Appendectomy Versus Conventional Multiport Appendectomy: a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
208 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Conventional laparoscopic appendectomy(CLA) is the current standard treatment. To obtain additional benefits such as a better cosmetic outcome, the investigators developed a surgical option termed suprapubic single-incision laparoscopic appendectomy (SSILA), which creates a non-visible scar, that was preliminarily shown to be feasible and safe in our previous retrospective studies To further evaluate the feasibility, safety and cosmetic results of this innovative approach, the investigators compared the outcomes of SSILA and CLA by performing a randomized controlled trial.

Conditions

Interventions

TypeNameDescription
PROCEDUREsuprapubic single-incision laparoscopic appendectomythe approach of appendectomy

Timeline

Start date
2015-06-01
Primary completion
2017-12-01
Completion
2018-12-01
First posted
2015-07-15
Last updated
2015-07-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02499016. Inclusion in this directory is not an endorsement.

Suprapubic Single-incision Laparoscopic Appendectomy Versus Conventional Appendectomy: a Randomized Controlled Trial (NCT02499016) · Clinical Trials Directory